It’s been nearly 3 years since Procos USA, Inc. was established back in July 2019, and this US subsidiary of Procos SpA is really taking hold of the US market.  While the Italian based CDMO, Procos SpA, has always had a deep-rooted business here in the US, long before its first successful FDA inspection in 1982, the company is growing its name, its people and its relationships with its US based business partners like never before. 

The leadership stands strong with executives from Procos SpA and the mother company CBC Group who make up the Board of Directors, as well as by seasoned industry leaders who manage the US operations and business development activities including Alicia Xaka, Associate Director, Business Development, who has spent 17 years working across the pharmaceutical and medical device industries and the last 7 years as part of the CBC/Procos team, and Patricia Luhrs, Sales Office Manager, who is a 25 year veteran of API sales, marketing and logistics, joining Procos in 2019, several months after the US based company was implemented.  And more recently the team welcomed its newest member, Jerod Patzner, Manager of Business Development, Custom Synthesis, who has 12 years of experience working across various technical sales roles and is a trained process chemist.

“We’ve worked so hard over the years to build up the Procos SpA name here in the US and finally the company is being recognized, especially after Procos USA was officially born,” said Alicia Xaka.  “The team is seeing a lot of new business opportunities in both clinical manufacturing and the generic space as Procos continues to invest in new technologies and we are excited to watch this small CDMO blossom into an industry leader in the small molecule API space, especially as we ramp up the manufacturing capacity at the site in Italy.”

Procos USA team will join the upcoming CPhI North America conference, taking place at the Philadelphia Convention Center, May 17-19, 2022, to showcase the CDMO capabilities offered by Procos SpA, specifically focusing on the latest technology investments related to API process development and manufacturing, including its high potency suites, flow chemistry equipment, the CHEMSPEED module, as well as its global Generics API portfolio.  Please stop by the booth (#1835), to meet the Procos USA team and learn more about how they can support your next API development project.

Please contact US-Sales@procos.it